Clinical Trial Update: Gender Response To Coronary Risk

View source ↗

Summary

The document reports the completion of a NHLBI-sponsored clinical trial examining gender differences in response to coronary risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED